Nuvation Bio is trading $6.54 (+5.23%) higher during the August 17, 2026 session, with no new company-specific announcement or scheduled event identified.
- Recent coverage centers on August 6 second-quarter results and August 7 analyst target increases, rather than a fresh catalyst on August 17.
- Broader markets are mixed, so the gain is not clearly explained by market-wide momentum.